The Living Cure: The Promise of Cancer Immunotherapy | Stansberry Research
The Living Cure: The Promise of Cancer Immunotherapy
It's one of the most chilling things a person can hear... "You have cancer." Two in five Americans will receive a cancer diagnosis at some point in their lives. For decades, cancer was removed by surgery or "blown up" by radiation and chemotherapy... but you never escaped the feeling that you're living on borrowed time. For the first time in decades, you have a choice... an option to get better in weeks, rather than years (or worse)... an alternative to poisonous radiation and chemotherapy. In The Living Cure, you'll find a real, science-backed alternative to poisonous chemotherapy and radiation... where to go if anyone you know is faced with this horrible disease... how to access incredible treatments not available to the general public... one decision that could instantly double your chance of survival... and much more. Dr. David Eifrig is certain this research could save your life or the life of a loved one.
Download Now or Order Physical Copy
Order Here
Book Details
Pages: 46
Published: 2015
About the Author

Dr. David "Doc" Eifrig has one of the most remarkable resumes of anyone we know in the finance industry. After receiving his Bachelor of Arts degree from Carleton College in Minnesota, he went on to earn a Master of Business Administration degree

from Northwestern University's Kellogg School of Management. There, he graduated on the Dean's List with a double major in finance and international business.

Doc then went to work as an elite derivatives trader at the Goldman Sachs investment bank. He spent a decade on Wall Street with several major institutions, including Chase Manhattan Bank and Yamaichi Securities (then known as the "Goldman Sachs of Japan").

That's when Doc's career took an unconventional turn. Sick of the greed and hypocrisy on Wall Street, he quit his Senior Vice President position to become a doctor. He graduated from Columbia University's postbaccalaureate premedical program and eventually earned his Medical Doctor degree with clinical honors from the University of North Carolina at Chapel Hill. While in medical school, he was elected president of his class and admitted to the Order of the Golden Fleece – the highest honor awarded at the university.

Doc also completed a research fellowship in molecular genetics at Duke University and became a board-eligible eye surgeon. Along the way, he has been published in scientific journals and helped start a small biotechnology company, Mirus Bio, which was sold to Roche for $125 million in 2008.

However, frustrated by Big Medicine's many conflicts, Doc began to look for ways to talk directly with individuals. He wanted to use his background to show them how to take control of their health and wealth. In 2008, Doc joined Stansberry Research and launched his publication, Retirement Millionaire. He has gone on to launch Retirement Trader, which uses options to help people construct safe, reliable income streams. Doc's Income Intelligence seeks out income-producing investments to maximize returns. Prosperity Investor helps investors unlock massive potential gains in health care investing. Every Monday through Friday, Doc shares his views on the latest in the financial and health industries – and tips on how to improve your own life – in Health & Wealth Bulletin.

Doc has also authored five books with four-star ratings (or better) on Amazon. In his spare time, he has run three marathons and several triathlons. He owns and produces his own wine (Eifrig Cellars) in northern Sonoma County, California. Doc is also the CEO of MarketWise, Stansberry Research's parent company.

Back to Top